MedTech & Diagnostics
Option Care Health Executive Compensation (FY25)
OPCH · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025 ◇ John Rademacher | Median of the other named officers $2,177,369 5 officers, excluding the chief executive | Latest say-on-pay support = May 20, 2026 | Chief executive pay ratio ◇ To the median employee |
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
The Option Care Health brief, $500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $900.
Data as of November 4, 2026Latest filing (8-K): May 22, 2026
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Intel, one year, every company
358 figures on this page: 349 cited to the filing that reported them, 9 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — John Rademacher: $8,222,800 → $9,266,330 (12.7% higher)
CEO pay ratio: 154:1 → 167:1 (8.4% higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is Option Care Health's chief executive and what were they paid?
Total compensation for John Rademacher, President and Chief Executive Officer, came to $9,266,330 in fiscal 2025. Rademacher's total was 12.7% higher than the $8,222,800 reported for fiscal 2024.
What was Option Care Health's say-on-pay result?
For fiscal 2025, the say-on-pay proposal drew 97.1% support at the meeting held May 20, 2026.
Which companies are in Option Care Health's peer group?
The disclosed peer group includes Acadia Healthcare Company, Inc., AdaptHealth Corp., Addus HomeCare Corporation, agilon health, inc. and Amedisys, Inc., among others.
What is Option Care Health's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 167:1, against median employee compensation of $55,342.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
John Rademacher President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Michael Shapiro Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Richard Denness Former Chief Commercial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Collin Smyser General Counsel and Corporate Secretary | ◇ | ◇ | ◇ | ◇ | ◇ | — | — | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
John Rademacher President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Michael Shapiro Chief Financial Officer | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Luke Whitworth Chief Operating Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Collin Smyser General Counsel and Corporate Secretary | ◇ | ◇ | ◇ | ◇ | ◇ | — | — | ◇ |
Michael Bavaro Chief Human Resources Officer | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Richard Denness Former Chief Commercial Officer Departed during or after this year | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
John Rademacher President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Michael Shapiro Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Luke Whitworth Chief Operating Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Collin Smyser General Counsel and Corporate Secretary | ◇ | — | ◇ | — | ◇ | — | ◇ | — not reconciled |
Christopher Grashoff Chief Growth Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | — not reconciled |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
John Rademacher President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Luke Whitworth Chief Operating Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Michael Shapiro Former Chief Financial Officer Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Collin Smyser General Counsel and Corporate Secretary | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Christopher Grashoff Chief Growth Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Meenal Sethna Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | — | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Christopher L. Grashoff | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Christopher L. Grashoff | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Collin G. Smyser | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Collin G. Smyser | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| John C. Rademacher | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| John C. Rademacher | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Luke Whitworth | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Luke Whitworth | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Meenal A. Sethna | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Michael Shapiro | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Michael Shapiro | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
Fiscal 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| John Rademacher | Option | ◇ | — | ◇ | 02/22/2033 |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 02/22/2033 | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 02/21/2032 | |
| RSU | ◇ | ◇ | — | — | |
| Michael Shapiro | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 06/30/2026 | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 06/30/2026 | |
| Meenal Sethna | RSU | ◇ | ◇ | — | — |
| Luke Whitworth | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 02/22/2033 | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 02/22/2033 | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 02/17/2032 | |
| RSU | ◇ | ◇ | — | — | |
| Collin Smyser | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 02/22/3033 | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 02/22/2033 | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 05/19/2032 | |
| RSU | ◇ | ◇ | — | — | |
| Christopher Grashoff | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 02/22/2033 | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 02/17/2032 | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Michael Shapiro
Former Chief Financial Officer · Severance agreement · dated August 19, 2025
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
Christopher Grashoff
Chief Growth Officer · Severance agreement
| Severance multiple | ◇ |
| Benefits continuation | ◇ |
Collin Smyser
General Counsel and Corporate Secretary · Severance agreement
| Severance multiple | ◇ |
| Severance base | ◇ |
| Change-in-control multiple | ◇ |
| Change-in-control base | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
John Rademacher
President and Chief Executive Officer · Severance agreement
| Benefits continuation | ◇ |
Luke Whitworth
Chief Operating Officer · Severance agreement
| Severance multiple | ◇ |
| Severance base | ◇ |
| Benefits continuation | ◇ |
Meenal Sethna
Chief Financial Officer · Severance agreement
| Severance multiple | ◇ |
| Severance base | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Harry M. Jansen Kraemer, Jr Board chair | ◇ | ◇ | — | — | — | — | ◇ |
R. Carter Pate | ◇ | ◇ | — | — | — | — | ◇ |
Natasha Deckmann, M.D | ◇ | ◇ | — | — | — | — | ◇ |
Norman L. Wright | ◇ | ◇ | — | — | — | — | ◇ |
Elizabeth Q. Betten | ◇ | ◇ | — | — | — | — | ◇ |
Eric K. Brandt | ◇ | ◇ | — | — | — | — | ◇ |
Barbara W. Bodem | ◇ | ◇ | — | — | — | — | ◇ |
Elizabeth D. Bierbower | ◇ | ◇ | — | — | — | — | ◇ |
Timothy P. Sullivan | ◇ | ◇ | — | — | — | — | ◇ |
David W. Golding | ◇ | ◇ | — | — | — | — | ◇ |
John C. Rademacher served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Equity is delivered as restricted stock units.
Stock ownership guideline: 3x annual cash retainer for Board service
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Acadia Healthcare Company, Inc. ACHC
- AdaptHealth Corp. AHCO
- Addus HomeCare Corporation ADUS
- agilon health, inc. AGL
- Amedisys, Inc. AMED
- AMN Healthcare Services, Inc. AMN
- BrightSpring Health Services, Inc. BTSG
- Chemed Corporation CHE
- DaVita Inc. DVA
- Encompass Health Corporation EHC
- Enhabit Inc. EHAB
- Labcorp Holdings Inc. LH
- Owens & Minor, Inc. ACH
- Patterson Companies, Inc. PDCO
- Quest Diagnostics Incorporated DGX
- Select Medical Holdings Corporation SEM
- Surgery Partners, Inc. SGRY
- The Ensign Group, Inc. ENSG
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | May 20, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | May 14, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | May 15, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | May 17, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | May 18, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | May 19, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | May 22, 2020 | = | ◇ | ◇ | ◇ |
| 2017 | May 3, 2018 | = | ◇ | ◇ | ◇ |
| 2016 | May 2, 2017 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- John Rademacher (President and Chief Executive Officer), FY2025 total compensation $9,266,330 (base salary $1,000,000) [exec_comp, SEC accession 0001140361-26-013825, filed 2026-04-08]What this page does not include
Everything above is a fact Option Care Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Option Care Health sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
358 figures on this page: 349 cited to the filing that reported them, 9 calculated from figures it prints.
349 cited to the filing
9 calculated from the filing
Documents cited
- 0001014739-26-000017Non-Votes 149,076,945 1,132,306 49,362 N/A 3.
- 0001140361-26-0138252025 Non-Employee Director Compensation · 2025 Non-Employee Director Compensation Program · CEO Pay Ratio · Grants of Plan-Based Awards · and 1 more section
- 0001104659-25-080912EXHIBIT 10.2
- 0001014739-25-000028
- 0001140361-25-011852Executive Compensation Tables
- 0001014739-24-000025
- 0001140361-24-017579Executive Compensation Tables
- 0001014739-23-000022Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001014739-22-000028
- 0001014739-21-000024
- 0001104659-20-067097
- 0001144204-18-025220Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001144204-17-024374Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Option Care Health executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/OPCH (accessed 2026).
Short form: data: Velarion
The Option Care Health brief, $500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $900.
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Option Care Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
MedTech & Diagnostics rankings
Peers Option Care Health discloses
The companies named in OPCH's own disclosed peer group.
Acadia Healthcare Company, Inc.AdaptHealth Corp.Addus HomeCare Corporationagilon health, inc.AMN Healthcare Services, Inc.BrightSpring Health Services, Inc.Chemed CorporationDaVita Inc.Encompass Health CorporationEnhabit Inc.Labcorp Holdings Inc.Owens & Minor, Inc.Patterson Companies, Inc.Quest Diagnostics IncorporatedSelect Medical Holdings CorporationSurgery Partners, Inc.The Ensign Group, Inc.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}